Overview of QQ3 2024 results shows HNO International Inc reporting a modest revenue line but a substantial operating loss driven by outsized operating expenses. Revenue reported at 4,241 (USD) with gross profit of 553 and a gross margin of approximately 13.0%. However, operating expenses of 490,250 and related line items (G&A 430,693; SG&A 440,286; other operating costs 46,276) produced an operating loss of 496,621 and an EBITDA of -439,726, yielding an EBITDARatio of -103.68% and a net income of -496,621 (net margin -117.10%). The company carries a highly leveraged balance sheet with total debt of 1,511,719 and total liabilities of 2,399,206 against total assets of 1,414,495 and negative stockholders’ equity (-984,711). Liquidity is severely constrained, evidenced by an implied current/quick/cash ratio of 0.0457, and a cash burn narrative in operating activities (-428,805) despite financing activity inflows (+522,877) from equity issuances (common stock issued: 494,528). Free cash flow is negative at -577,800. Management commentary is not captured in the provided transcript (no earnings call transcript available). Looking ahead, the lack of explicit QQ3 2024 forward guidance and the fragile liquidity position suggest the near-term path to profitability depends on scaling revenue, controlling fixed costs, and potential capital-raising or deleveraging actions.